A B S T R A C T A spontaneously occurring rat adrenocortical carcinoma which produces corticosterone was maintained by transplantation. The In normal adrenals, ACTH increases the activity of adenyl cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to adenosine-3',5'-monophosphate (cyclic AMP), the latter then serving as an intracellular regulator of steroidogenesis. ACTH failed to increase cyclic AMP levels in the tumor in vivo or in slices in vitro, conditions under which there were 50-and 20-fold increases in nontumorous adrenals. However, in homogenates fortified with exogenous ATP, adenyl cyclase activity was comparable in the tumor and adrenals, and cyclic AMP formation was increased 3-fold by ACTH in each. As measured in homogenates, the tumor did not possess a greater ability to destroy cyclic AMP than did normal adrenals. Although ATP levels in the carcinoma were found to be considerably lower than those in normal adrenals, it was not clear that this finding can explain the inability of ACTH to increase cyclic AMP levels in intact tumor cells.
A B S T R A C T A spontaneously occurring rat adrenocortical carcinoma which produces corticosterone was maintained by transplantation. The carcinoma appeared to utilize corticosterone biosynthetic steps similar to those of the normal adrenal, but the tumor produced only about 1-10% as much corticosterone per unit tissue weight as nontumorous adrenal glands. The tumor demonstrated little or no increase in corticosterone production in response to adrenocorticotropic hormone (ACTH) either in vivo or in vitro.
In normal adrenals, ACTH increases the activity of adenyl cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to adenosine-3',5'-monophosphate (cyclic AMP), the latter then serving as an intracellular regulator of steroidogenesis. ACTH failed to increase cyclic AMP levels in the tumor in vivo or in slices in vitro, conditions under which there were 50-and 20-fold increases in nontumorous adrenals. However, in homogenates fortified with exogenous ATP, adenyl cyclase activity was comparable in the tumor and adrenals, and cyclic AMP formation was increased 3-fold by ACTH in each. As measured in homogenates, the tumor did not possess a greater ability to destroy cyclic AMP than did normal adrenals. Although ATP levels in the carcinoma were found to be considerably lower than those in normal adrenals, it was not clear that this finding can explain the inability of ACTH to increase cyclic AMP levels in intact tumor cells.
While the failure to normally influence cyclic AMP levels in the carcinoma cells could be an important factor in the lack of a steroid response to ACTH, several lines of evidence suggest that the tumor possesses one or more additional abnormalities in the regulation of steroidogenesis. First, in the absence of ACTH stimula-
INTRODUCTION
It is well known that ACTH' has little or no stimulatory effect on steroid hormone biosynthesis in many adrenocortical carcinomas (1) . The present studies were undertaken to investigate possible factors which might account for this ACTH unresponsiveness. For this purpose, we have utilized a spontaneously occurring, transplantable rat adrenocortical carcinoma that was originally discovered by Snell and Stewart (2) . It has been shown previously that this carcinoma produces corticosterone, and that it is capable of utilizing progesterone and deoxycorticosterone as precursors in the formation of corticosterone (3) We have undertaken studies seeking to determine the reasons for the ACTH unresponsiveness of the adrenal carcinoma. In the normal adrenal cortex ACTH increases the activity of adenyl cyclase, which catalyzes the conversion of ATP to cyclic AMP. The cyclic AMP in turn serves as an intracellular mediator of the action of ACTH on steroidogenesis (4-6). Cyclic AMP accelerates the conversion of cholesterol to A5-pregnenolone (7), which in turn is rapidly converted to corticosterone in the rat adrenal. In an effort to dissect the reasons for the ACTH unresponsiveness of the rat adrenocortical carcinoma, the following questions were examined: does ACTH normally increase cyclic AMP concentrations in the tumor? And does cyclic AMP in turn accelerate steroidogenesis in the carcinoma as it does in the nontumorous adrenal cortex ?
METHODS
Adrenocortical carcinoma 494 is a spontaneously occurring tumor that was originally discovered in Osborne-Mendel rats by Snell and Stewart (2) . The histological features of the tumor have been previously described by these authors (2) . We have maintained the tumor by transplantation in both the original strain of Osborne-Mendel rats in which it was discovered and in Sprague-Dawley rats. The growth rate and corticosterone synthetic activity of the tumor has appeared to be similar in these two strains. For transplantation, necrotic portions of the tumor were removed, and the residual tumor was minced into small pieces. The tumor pieces, about 2-3 mm in diameter, were implanted either intraperitoneally or subcutaneously with a trochar into rats weighing 60-80 g. Approximately 50% of the rats receiving implants subsequently developed demonstrable tumor masses. In successful transplants, tumor masses of about 2-8 g were present after 4-8 wk. At this time, the tumor was removed and utilized either for retransplantation or for incubation studies.
In vitro studies of steroidogenesis by tumor tissue or adrenal glands were carried out by similar methods. Tumor tissue free of necrosis was sliced and incubated in quantities of 100-250 mg of tissue per flask. Quartered nontumorous adrenal glands from control or tumor-bearing animals were also studied. The incubation medium was Krebs-Ringer bicarbonate buffer containing 200 mg/100 ml of glucose. Incubations were carried out in an atmosphere of 95%o 0-5% CO2 at 370 C in a water bath with shaking. After a 30 min period of preincubation in 2 ml of buffer only, the incubation medium was aspirated, and 2 ml fresh medium was added, containing additions as described. The final incubation was then carried out for 2 hr. After the incubation, the tissues were homogenized in the 2 ml buffer of the final incubation, and corticosterone was measured in the homogenate. The corticosterone produced by either nontumorous adrenal glands or by the adrenal carcinoma was expressed as Aig/100 mg of tissue per hr of incubation.
Corticosterone was measured in plasma and in adrenal and tumor incubations by the method of Silber, Busch, and Oslapas (8) . Cholesterol was assayed in the adrenal carcinoma by the method of Sperry and Webb (9) .
Tissue concentrations of cyclic AMP were assayed using methods described previously (6, 10) . In the in vivo experiments tissues were excised, rapidly weighed, and assayed for their cyclic AMP content. In the in vitro experiments tumor slices or quartered adrenals were weighed and incubated in 2 ml of Krebs-Ringer bicarbonate buffer at 37'C for 30 min. At the conclusion of the incubation the tissues were removed and assayed for their cyclic AMP content.
Adenyl cyclase activity in homogenates of normal rat adrenals and of the adrenocortical carcinoma was assayed as described previously (6) . Cyclic AMP formation in the presence of added substrate ATP (2 mmoles/liter) served as the index of enzyme activity. Caffeine, an inhibitor of nucleotide phosphodiesterase activity, was added at a concentration of 6.67 mmoles/liter in order to slow cyclic AMP breakdown. Incubations of the homogenates were carried out at 30'C for 15 min in a water bath with shaking. 1 U of adenyl cyclase activity refers to the production of a micromole of cyclic AMP in 1 min.
Cyclic 3',5'-nucleotide phosphodiesterase activity, which catalyzes the conversion of cyclic AMP to 5'-AMP, was assayed in homogenates of normal adrenals and tumor tissue according to methods previously described (11, 12) . 1 U of enzyme activity refers to the production of 1 omole of 5'-AMP from cyclic AMP in 1 min at 30'C.
Tissue concentrations of ATP were assayed by the method of Lowry, Passonneau, Hasselberger, and Schultz (13) .
RESULTS
Effects of ACTH, cyclic AMP, and NADPH on corticosterone production in the adrenocortical carcinoma and in nontumorous adrenal glands. Initially corticosterone production was evaluated in tumor-bearing animals in vivo both before and after the administration of ACTH. Blood was obtained from the femoral vein for corticosterone assay. Plasma corticosterone was approximately three times normal in the tumor-bearing animals (Table I) . 30 min atfer the intravenous injectinon of 1 U of ACTH ' there was a clear increase in plasma corticosterone in control animals, whereas there was no increase in the tumor-bearing animals. Adrenals from the tumor-bearing rats were atrophic, ranging in weight from (Table III) , in marked contrast to the findings with the nontumorous adrenals from these same animals (Table II) . Thus, while the limited responses of the atrophic nontumorous adrenals could be ascribed to chronic ACTH suppression, this same reasoning could not explain the limited responses of the carcinoma. Studies of the corticosterone biosynthetic pathway in the adrenocortical carcinoma. One possible explanation for the ACTH insensitivity of the adrenal carcinoma was that the tumor by-passed ACTH-sensitive steps in the biosynthesis of corticosterone. Alternatively, the corticosterone biosynthetic sequences might have been qualitatively similar in the carcinoma and in the normal adrenal, but the tumor possessed other defects which limited the action of ACTH. In the normal rat adrenal, cholesterol is converted through a series of reactions to A5-pregnenolone. It is this conversion that is stimulated by ACTH in its action to accelerate steroidogenesis (7). Subsequent reactions lead sequentially from A5-pregnenolone to progesterone, deoxycorticosterone, and finally corticosterone (15) .
The adrenal carcinoma was found to contain cholesterol in a concentartion of 0.21 ±0.01 mg/100 mg of tissue (mean +SEM, four animals), a value similar to that reported by Lossow, Shyamala, Shah, and Chaikoff for this tumor (16) but considerably less than that observed in normal adrenals (17) . Aminoglutethimide has been shown to inhibit the conversion of cholesterol to Apregnenolone, thereby diminishing corticosterone production by the normal adrenal (18) . Tumor-bearing The number of observations is shown in parentheses. The data for incubations without additions are also shown in Table III .
All values are expressed as mean ±SEM. (Table I ). In addition, corticosterone production was inhibited when the carcinoma was incubated with aminoglutethimide (Table  IV) . Although it is recognized that aminoglutethimide may have different effects in the carcinoma than in normal adrenals, the experiments do at least suggest that the conversion of cholesterol to A5-pregnenolone lies in the pathway of corticosterone synthesis in the carcinoma. When the conversion of cholesterol to A5-pregnenolone is inhibited by aminoglutethimide, then corticosterone production is accordingly decreased. Similarly, Schteingart, Cash, and Conn found that aminoglutethimide inhibited cortisol production by a human adrenocortical carcinoma (19) . In the normal adrenal, once A5-pregnenolone is formed under the influence of ACTH it is readily converted to corticosterone through a series of steps involving progesterone and deoxycorticosterone as intermediates. Accordingly, when adrenals are incubated with exoge- The tissues were incubated for 30 min. At the end of this period, the tissues were removed from the incubation medium and assayed for cyclic AMP. The number of observations is indicated in parentheses. The data for the normal adrenals have been reported previously (6) . All values are expressed as mean 4SEM.
nous A5-pregnenolone, progesterone, or deoxycorticosterone, the formation of corticosterone is increased (20) . To test whether the adrenocortical carcinoma could also perform this series of reactions, tumor tissue was incubated with exogenous A5-pregnenolone or progesterone, and it was found that corticosterone production was enhanced (Table IV) . Previous studies have shown the conversion of tracer quantities of isotopically labeled progesterone and deoxycorticosterone to corticosterone by this tumor (3). It would therefore appear that the tumor possesses the capacity to carry out certain reactions in corticosterone biosynthesis that are found in the normal adrenal. Cyclic AMP concentrations in the adrenocortical carcinoma and in nontumorous adrenals. Studies were performed to determine whether the failure of ACTH to increase corticosterone biosynthesis in the carcinoma might be due to a failure to increase tissue cyclic AMP concentrations. When the carcinoma and nontumorous adrenals were removed from tumor-bearing animals, the concentrations of cyclic AMP in the two tissues were not greatly different (Table V) . When the tumor-bearing animals were injected with 20 U of ACTH in the femoral vein and the tissues excised 5 min later, there was only a small increase in cyclic AMP levels in the tumor but a 50-fold increase in the cyclic AMP levels in nontumorous adrenals of these same animals.
When tumor slices and quartered adrenals were incubated for 30 min in vitro in the absence of ACTH, concentrations of cyclic AMP in the two tissues were comparable. When ACTH, 1 U/ml, was present in the incubation medium there was a 20-fold increase in cyclic AMP levels in the adrenals but little change in the tumor (Table VI) .
Phosphodiesterase activity in the tumor and in nontumorous adrenals. One possible explanation for the inability of ACTH to increase tumor cyclic AMP levels would be a rapid rate of degradation of the cyclic nucleotide. This degradation is accomplished at least partly by the enzyme cyclic nucleotide phosphodiesterase which catalyzes the conversion of cyclic AMP to 5'-AMP (11, 12) . The possible participation of other pathways of cyclic AMP metabolism has not been excluded. Phos- (2) All values are expressed as mean +SEM.
phodiesterase activity was assayed and found to be lower in homogenates of the adrenocortical carcinoma than in homogenates of normal adrenals (Table VII) .
In an additional experiment, tumor slices were incubated with 10 mm caffeine for 30 min. Caffeine inhibits phosphodiesterase activity, and it was considered possible that a stimulatory effect of ACTH on cyclic AMP formation might be uncovered under these conditions. When tumor slices were incubated with caffeine alone, the tissue concentration of cyclic AMP was 6.05 nmoles/ g, a value somewhat higher than that observed when the tumor was incubated under identical conditions but without caffeine (Table VI) (21) . The reason for the decreased ATP concentrations in the tumor remains to be clarified. It also remains to be established whether other factors are important in the failure of ACTH to increase cyclic AMP levels in intact tumor cells. For example, the presence of inhibitors of adenyl cyclase activity or an abnormal subcellular distribution of the enzyme making it inaccessible to ACTH could be important factors.
It is clear that the failure of ACTH to increase tumor cyclic AMP concentrations could impose an important limitation on the stimulation of steroidogenesis in this tissue. Several lines of evidence, however, suggest that the tumor possesses additional abnormalities in the regulation of steroidogenesis. First, base line concentrations of cyclic AMP (in the absence of added ACTH) were similar in the carcinoma and in adrenals (Tables V,  VI ). However, this same level of tissue cyclic AMP was associated with a much lower level of steroidogenesis in the tumor than in adrenals (Tables II, III) . Furthermore, when tumor slices were incubated with added cyclic AMP, there was little increase in corticosterone production (Table III) in contrast to the marked increase observed with nontumorous adrenals (Table II) . One possibility that cannot be excluded from the present studies is that the tumor is composed of a heterogeneous cell population. Although marked heterogeneity is not evident from histological observations (2) , it is possible that the cells are heterogeneous in function. Thus only a small percentage of the cell population might be active in steroid production, and these cells might be functioning at a maximal rate rendering them insensitive to further stimulation.
